Maxim Group Thinks Restoration Robotics Inc’s Stock is Going to Recover

By Carrie Williams

In a report released today, Anthony Vendetti from Maxim Group maintained a Buy rating on Restoration Robotics Inc (HAIRResearch Report), with a price target of $6. The company’s shares closed yesterday at $0.87, close to its 52-week low of $0.35.

Vendetti wrote:

“Market open, HAIR reported better-than-expected preliminary 4Q18 revenue and system shipments. The company completed its Standards audit, which represents a major milestone towards final CE Mark clearance for the ARTAS iX System. 2018, HAIR filed for a mixed shelf of up to $100M. The company plans to report full 4Q18 results in early March 2019.”

According to, Vendetti is a 4-star analyst with an average return of 3.1% and a 49.6% success rate. Vendetti covers the Healthcare sector, focusing on stocks such as Xtant Medical Holdings, Ra Medical Systems Inc, and Sensus Healthcare Inc.

Currently, the analyst consensus on Restoration Robotics Inc is a Moderate Buy with an average price target of $5.25.

See today’s analyst top recommended stocks >>

The company has a one-year high of $8.20 and a one-year low of $0.35. Currently, Restoration Robotics Inc has an average volume of 259.8K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Restoration Robotics, Inc. manufactures and develops medical devices for hair transplantation services. It provides artas system, a computer-assisted, physician-controlled system to harvest follicular units directly from the scalp.